Jung, Y.-H., Kim, H., Kim, H., Kim, E., Baik, J., & Kang, H
Prior attempts to manage diabetes through diet or exercise
Researchers exploring semaglutide versus tirzepatide side effects find broadly similar GI profiles between the two medications
Using the drug after this timeframe may compromise its effectiveness and safety
Human case series from European clinics report significant improvement in inflammatory bowel disease symptoms, though large-scale randomized controlled trials remain limited
Therefore, targeting the intestinal barrier with dietary bioactive L-SOD could be a promising glucose-lowering approach to reset HMRD-induced new onset diabetes in PASC patients